NCT05827081 2026-04-14
Adjuvant WIDER
Novartis
Phase 3 Recruiting
Novartis
Eastern Cooperative Oncology Group
SWOG Cancer Research Network
Proton Collaborative Group
Instituto de Investigación en OncologÃa Radioterápica - Fundación Española de OncologÃa Radioterápic